Cure Tuberculosis Project

The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens.
The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens.

Duration: July 2019 – July 2024

Budget: $18,450,292

Implementing Partner: JSI Research & Training Institute, Inc. (JSI) in partnership with the University Research Co., LLC (URC)

Key Partners: Ministry of Health of the Kyrgyz Republic, National Tuberculosis Program (NTP), Mandatory Health Insurance Fund (MHIF)

Activity Locations: Countrywide

The USAID Cure Tuberculosis Project is an $18.5 million investment over five years that will assist the Kyrgyz government to diagnose, treat, and cure people with drug-resistant tuberculosis.

People at risk of tuberculosis (TB) are often among the hardest to reach, which can make it difficult for them to access health services. The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens. As stigma and discrimination often prevent people from getting the services they need, the Cure Tuberculosis Project will work to reduce tuberculosis stigma and discrimination among health care providers and the general public. 

The Cure Tuberculosis Project focuses on strengthening systems, tools, resources, and human capacity to improve the Kyrgyz Republic’s TB response in compliance with the latest international recommendations. The project will also strengthen the Kyrgyz government’s efforts to design, manage, and monitor a system of high-quality TB services available at local health care facilities and to create conditions where healthcare services meet the needs of the people. 

The Cure Tuberculosis Project is implemented by JSI Research & Training Institute, Inc. (JSI) in partnership with University Research Co., LLC (URC), and close collaboration with the Kyrgyz Republic’s National Tuberculosis Program under the Ministry of Health and national partners. 

MAJOR FOCUS AREAS

  1. Increase Drug-Resistant TB Case Detection. Strengthen laboratory and diagnostic services and expand detection and contact-tracing capabilities in communities and health facilities.
  2. Cure More Patients of Drug-Resistant TB. Ensure that all patients receive the correct treatment regimen with high-quality drugs and ensure all patients complete their treatment as directed.
  3. Prevent Drug-Resistant TB Infections. Improve infection control in health facilities and laboratories and improve patient, provider, and at-risk people’s behaviors around preventing, detecting, and treating TB. 
  4. Improve the Enabling Environment. Improve TB-related policies, optimize financing for TB services, enhance the use of TB data for decision-making, and reduce stigma and discrimination.

Last updated: April 02, 2020

Share This Page